Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 9, September 2013
L’OMS a ciblé 17 maladies comme des Maladies Tropicales Négligées. Ces maladies sont très différentes les unes des autres, mais elles ont comme point commun de toucher principalement les populations les plus pauvres. Elles maintiennent dans la pauvreté les populations ayant initialement un n...iveau de développement faible. Ces maladies coexistent au sein des mêmes populations, augmentant de ce fait leur vulnérabilité.
more
Selon les estimations du recensement général de la population et de l’Habitat (RGPH, 2006), le nombre de personnes en situation de handicap au Burkina Faso en 2012 est estimé à environ 168 000, soit 1,2% de la population totale. La Fédération burkinabè des associations pour la promotion des... personnes handicapées (FEBAH) évalue à 66% le nombre de personnes en situation de handicap n’ayant aucun niveau d’instruction et seulement 16,5% ayant atteint le niveau primaire. Ces estimations contrastent avec celles de l’OMS et de la Banque mondiale (15% de la population mondiale sont en situation de handicap). Le champ de l’éducation inclusive se caractérisant au Burkina Faso par une absence de données quantitatives systématisées, de telles contradictions peuvent avoir des effets négatifs sur la planification éducative et les efforts déployés par les différents partenaires pour atteindre l’EPT.
more
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by... national public health officials and managers of immunization programmes.
This paper focuses on the second licensed dengue vaccine, TAK-003 (Qdenga, Takeda), along with WHO’s position for its use, and provides an update on the first licensed dengue vaccine, CYD-TDV.
more
Introduction Un Plan humanitaire multisectoriel spécifique à la réponse COVID-19 a été développé en avril 2020 et constitue un Addendum au Plan de réponse humanitaire 2020 (PRH) afin d’intégrer l’impact de la pandémie de COVID-19 sur les besoins humanitaires existants et sur les activi...tés des partenaires humanitaires en République Démocratique du Congo (RDC).
more
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a...nd on society through loss of productivity in the workplace and, espacially for pediatric asthma, disruption to the family.
more
Article published in: Journal of Intensive Care (2015) 3:16
A collaborative project of World Health Organization and
Lifting The Burden
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more
This volume contains monographs prepared at the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met virtually online from 1 to 12 February 2021.
The detailed monographs in this volume summarize data on specific contaminants in food. Individual monographs ...present the assessment of exposure to cadmium from all food sources, the technical, analytical, dietary exposure and toxicological data on ergot alkaloids, an assessment of five substances that may occur as previous cargoes, and a revision of the specifications for steviol glycosides. This volume and others in the WHO Food Additives series contain information that is useful to those who produce and use food additives and veterinary drugs and those involved with controlling contaminants in food, government and food regulatory officers, industrial testing laboratories, toxicological laboratories and universities.
more
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...is document has been updated: version 15 March 2022.
more